InvestorsHub Logo
Followers 470
Posts 76416
Boards Moderated 3
Alias Born 03/31/2008

Re: dDT post# 40422

Thursday, 10/23/2014 7:38:20 AM

Thursday, October 23, 2014 7:38:20 AM

Post# of 53906
CELG Celgene beats by $0.02, beats on revenue

Celgene (NASDAQ:CELG): Q3 EPS of $0.97 beats by $0.02.
Revenue of $1.98B (+18.6% Y/Y) beats by $20M.
Shares -0.34% PM.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.